HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 18.051 ↓ -0.06%
[as on 6 March, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 6 March, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 2.25% -0.06% -1.31% 4.26% 1.23% 16.75%----
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -6.88% -0.48% -2.33% -2.98% -7.15% 0.58% 13.01% 15.94% 15.17% 15.96%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -5.68% -1.18% -3.5% -3.99% -6.28% 8.33% 13.66% 11.75% 13.69% 13.62%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 2.01% -0.09% -0.62% 4.31% 0.05% 8.52% 27.17% 18.41% 21.54% 13.29%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -4.22% -0.61% -3.2% -3.17% -3.24% 8.99% 20.54% 19.96% 19.54% 17.48%
SBI PSU Fund - DIRECT PLAN - GROWTH 6.09% -0.46% -2.93% 1.91% 8.44% 29.55% 33.66% 28.09% 21.61% 17.17%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns--------52.37%1.73%

Discrete returns (monthly)

MonthMay 2025Jun 2025Jul 2025Aug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026
Returns1.02%3.88%5.33%-1.45%-1.45%2.16%1.22%-1.38%-4.65%6.99%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns7.68%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.31% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.69%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.70%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.87%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology6.67%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.05%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology5.83%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.49%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology4.12%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology3.80%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services3.71%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology3.63%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services3.61%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology3.50%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals & Biotechnology2.89%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology2.88%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology2.86%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services2.46%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.33%
Dr. Lal Path Labs LtdLALPATHLAB (INE600L01024)Healthcare Services1.88%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology1.78%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.72%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.68%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.58%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.50%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.29%
Pfizer Ltd.PFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.29%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology1.27%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology1.05%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies1.03%
Rubicon Research LimitedRUBICON (INE506V01022)Healthcare Services1.00%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services0.95%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology0.89%
Portfolio data is as on date 31 October, 2025

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history

DateNAV
6 March, 202618.051
5 March, 202618.061
4 March, 202617.835
2 March, 202618.144
27 February, 202618.291
26 February, 202618.436
25 February, 202618.241
24 February, 202618.037
23 February, 202618.032
20 February, 202617.854
19 February, 202617.873
18 February, 202617.973
17 February, 202617.918
16 February, 202617.814
13 February, 202617.678
12 February, 202617.958
11 February, 202617.934
10 February, 202617.701
9 February, 202617.621
6 February, 202617.313
5 February, 202617.347
4 February, 202617.235
3 February, 202617.261
2 February, 202616.832
30 January, 202616.958
29 January, 202616.833
28 January, 202616.943
27 January, 202616.906
23 January, 202616.867
22 January, 202617.081

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 18.051 as on 6 March, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 2.25% as on 6 March, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 16.75% as on 6 March, 2026.